|

Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery

RECRUITINGN/ASponsored by Augusta University
Actively Recruiting
PhaseN/A
SponsorAugusta University
Started2023-05-10
Est. completion2025-05-11
Eligibility
Healthy vol.Accepted
Locations1 site

Summary

To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patient weight 3.5-12kg
* Elective and urgent cardiac surgery with cardiopulmonary bypass
* Cases within the STS STAT categories of 1-4

Exclusion Criteria:

* Patients who weigh more than 12kg or less than 3.5kg.
* Patients undergoing emergency surgery.
* STAT category 5 cases.
* Patients whose surgery does not require cardiopulmonary bypass.
* Patients presenting preoperatively in shock.
* Patients with known blood dyscrasias.

Conditions2

Congenital Heart DiseaseHeart Disease

Locations1 site

Children's Hospital of Georgia
Augusta, Georgia, 30912
Lauren Allen706-721-7608lauallen@augusta.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.